RK

Ravi Kumar

Active Director Director DIN 09076830
DIN 09076830 First appointment Feb 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Ravi Kumar

Data last updated:

Ravi Kumar is a Director at Surchlife Biotech Private Limited (since 2021). The company operates in Trading. Surchlife Biotech Private Limited reported revenue of ₹39.3 Lakh (FY 2025).

DIN 09076830
Primary Designation Director
Industry Trading
First Appointment 22 Feb 2021
Oldest Company Age 5 yrs
Largest company Surchlife Biotech Private Limited · ₹39.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Surchlife Biotech Private Limited U51909HP2021PTC008377
Director22 Feb 20212021₹39.3 Lakh (FY 2025)Active

Board colleagues of Ravi Kumar

NameDINCompanyDesignation
Nitu Kumari Singh09076831Surchlife Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Surchlife Biotech Private Limited
Premium access

Shareholding and investment profile for Ravi Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Kumar

Ravi Kumar currently holds 1 directorship: Surchlife Biotech Private Limited (Director, since 22 Feb 2021, revenue ₹39.3 Lakh (FY 2025)).

Ravi Kumar was first appointed on 22 Feb 2021 as Director at Surchlife Biotech Private Limited.

The current boards of Ravi Kumar's companies include Nitu Kumari Singh (Surchlife Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available